z-logo
open-access-imgOpen Access
Pioglitazone Suppresses Inflammation In Vivo in Murine Carotid Atherosclerosis
Author(s) -
Kiyuk Chang,
Sanjeev Francis,
Elena Aïkawa,
JoseLuiz Figueiredo,
Rainer H. Köhler,
Jason R. McCarthy,
Ralph Weissleder,
Jorge Plutzky,
Farouc A. Jaffer
Publication year - 2010
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.110.206342
Subject(s) - in vivo , intravital microscopy , inflammation , matrix metalloproteinase , pioglitazone , medicine , pathology , chemistry , endocrinology , diabetes mellitus , biology , microcirculation , type 2 diabetes , microbiology and biotechnology
To investigate the effects of pioglitazone (PIO), a peroxisome proliferator-activated receptor γ agonist, on plaque matrix metalloproteinase (MMP) and macrophage (Mac) responses in vivo in a molecular imaging study.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom